The immunology of fibrogenesis in alcoholic liver disease

Archives of Pathology and Laboratory Medicine

Volumn 128, Issue 11, 2004, Pages 1230-1238

  Chedid, Antonio ^a,b   Arain, Selma ^a   Snyder, Ann ^b   Mathurin, Philippe ^c   Capron, Frédérique ^d   Naveau, Sylvie ^c  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERCELLULAR ADHESION MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDOTHELIUM CELL; FATTY LIVER; FEMALE; FIBROGENESIS; FRANCE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGY; KUPFFER CELL; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; PROTEIN EXPRESSION; SMOOTH MUSCLE; STEATOSIS; STELLATE CELL;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; ENDOTHELIAL CELLS; ETHANOL; FEMALE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KUPFFER CELLS; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED;

EID: 7444257862     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mallory FB. Cirrhosis of the liver: five different types of lesions from which it may arise. Bull Johns Hopkins Hosp. 1911;22:69-75.
2. Gall EA. Posthepatitic, postnecrotic and nutritional cirrhosis: a pathologic analysis. Am J Pathol. 1960;36:241-271.
3. Beckett AG, Livingston AV, Hill KR. Acute alcoholic hepatitis. Br Med J. 1961;2:1113-1119.
4. Beckett AG, Livingston AV, Hill KR. Acute alcoholic hepatitis without jaundice. Br Med J. 1962;2:580-582.
5. Edmondson HA, Peters RL, Reynolds TB, et al. Sclerosing hyaline necrosis of the liver in the chronic alcoholic: a recognizable clinical syndrome. Ann Intern Med 1963;59:646-673.
6. Alcoholic liver disease: morphological manifestations: review by an international group. Lancet. 1981;1:707-711.
7. Chedid A, Mendenhall CL, Gartside P, et al. Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 1991;86:210-216.
8. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
9. Martinez-Hernandez A. The hepatic extracellular matrix II: electron immunohistochemical studies in rats with CCl4-induced cirrhosis. Lab Invest. 1985;53: 166-186.
10. ZheQi, Nobuhiko A, Akira O, Akira T, Ueno H. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A. 1999;96:2345-2349.
11. Tsukamoto H, Gaal K, French SW. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis. Hepatology. 1990;12:599-608.
12. Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor β: implications for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology. 1990;11:599-605.
13. Sakakibara K, Saito M, Umeda M, Enaka K, Tsukada Y. Native collagen formation by liver parenchymal cells in culture. Nature. 1976;262:316-318.
14. Gressner AM, Lotfi S, Gressner G, Lahme B. Identification and partial characterization of a hepatocyte-derived factor promoting proliferation of cultured fat-storing cells (parasinusoidal lipocytes). Hepatology. 1992;16:1250-1266.
15. Nakano M, Lieber CS. Ultrastructure of initial stages of perivenular fibrosis in alcohol-fed baboons. Am J Pathol. 1982;106:145-155.
16. Mak KM, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology. 1988;8:1027-1033.
17. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest. 1990;86:1641-1648.
18. Waes LV, Lieber CS. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology. 1977;73:646-650.
19. Nasrallah SM, Nassar VH, Galambos JT. Importance of terminal hepatic venule thickening. Arch Pathol Lab Med. 1980;104:84-86.
20. Nakano M, Worner TM, Lieber CS. Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology. 1982;83:777-785.
21. Worner TM, Lieber CS. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA. 1985;254:627-630.
22. French SW, Miyamoto K, Wong K, Jui L, Briere L. Role of the Ito cell in liver parenchymal fibrosis in rats fed alcohol and a high fat-low protein diet. Am J Pathol. 1988;132:73-85.
23. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247-2250.
24. Wrana JL. Transforming growth factor-β signaling and cirrhosis [editorial]. Hepatology. 1999;29:1909-1910.
25. Roulot D, Sevcsik AM, Coste T, Strosberg AD, Marullo S. Role of transforming growth factor β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology. 1999;29:1730-1738.
26. Rockey DC, Fouassier L, Chung JJ, et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: potential for autocrine and paracrine effects on stellate cells. Hepatology. 1998;27:472-480.
27. Bataller R, Gines P, Nicolas JM, et al. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology. 2000;118: 1149-1156.
28. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med. 1999;5:226-230.